| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and carisoprodol 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and carisoprodol 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 300 mg and codeine 8 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 20 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and pravastatin 80 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and pravastatin 40 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and pravastatin 20 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 325 milligram and codeine 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 325 milligram and codeine 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin 81 mg and pravastatin 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 80 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin DL-lysine |
Is a |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin- and omeprazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing aspirin and omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin- and cyclizine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Buffered aspirin (substance) |
Is modification of (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum aspirin |
Is modification of (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aloxiprin (substance) |
Is modification of (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin DL-lysine |
Is modification of (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 81 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 800mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 227.5mg prolonged-release oral gum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300mg e/c tablet (substance) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 300mg e/c tablet (substance) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 25 mg and dipyridamole 200 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 300 mg rectal suppository |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 300 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and dipyridamole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Aspirin 325 mg and pravastatin 80 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and pravastatin 20 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing aspirin and oxycodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin- and carisoprodol- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 300 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 75 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 975 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and codeine 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 20 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 800 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and carisoprodol and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin 81 mg and pravastatin 80 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and oxycodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and butalbital and caffeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]